海南创新医保基金结算医药货款省级全域直付，减轻药企资金周转压力

Core Viewpoint - The implementation of direct settlement of medical payment funds in Hainan significantly reduces the cash flow pressure on pharmaceutical companies by shortening the payment collection cycle from 12 months to within 30 days [1][4][6]. Group 1: Policy Implementation - In August 2024, Hainan Province launched a direct settlement scheme for medical payment funds, addressing the long-standing issue of delayed payments to pharmaceutical companies [3][4]. - The scope of direct settlement has been expanded to include all drugs and medical supplies purchased through the provincial procurement platform, benefiting both public and private medical institutions [4][5]. Group 2: Financial Impact - Since the launch of the online payment system on December 2, 2024, approximately 42.52 billion yuan has been directly settled for 671 pharmaceutical companies, drastically reducing the average payment collection period [6]. - The estimated annual savings in interest costs for pharmaceutical companies is about 214 million yuan, based on a total procurement amount of 6.11 billion yuan in 2023 [6]. Group 3: Operational Efficiency - The new direct settlement model has improved payment efficiency and reduced operational costs for pharmaceutical companies, enhancing the stability of the supply chain and ensuring a steady supply of medications [5][6]. - The implementation of a prepayment mechanism helps alleviate cash flow pressures for medical institutions, ensuring timely payments to pharmaceutical companies [6][7].